Moors & Cabot’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-16,000
| Closed | -$64K | – | 825 |
|
|
2020
Q4 | $64K | Sell |
16,000
-1,000
| -6% | -$4.18K | 0.01% | 710 |
|
|
2020
Q3 | $63K | Sell |
17,000
-500
| -3% | -$2.11K | 0.01% | 669 |
|
|
2020
Q2 | $59K | Buy |
17,500
+1,500
| +9% | +$3.36K | 0.01% | 636 |
|
|
2020
Q1 | $20K | Sell |
16,000
-7,000
| -30% | -$11K | ﹤0.01% | 574 |
|
|
2019
Q4 | $31K | Sell |
23,000
-2,500
| -10% | -$4.18K | ﹤0.01% | 597 |
|
|
2019
Q3 | $51K | Sell |
25,500
-2,380
| -9% | -$4.86K | 0.01% | 607 |
|
|
2019
Q2 | $65K | Buy |
27,880
+3,880
| +16% | +$8.46K | 0.01% | 535 |
|
|
2019
Q1 | $64K | Buy |
24,000
+6,500
| +37% | +$19.7K | 0.01% | 510 |
|
|
2018
Q4 | $54K | Sell |
17,500
-3,000
| -15% | -$10.2K | 0.01% | 485 |
|
|
2018
Q3 | $69K | Sell |
20,500
-5,750
| -22% | -$30.5K | 0.01% | 571 |
|
|
2018
Q2 | $126K | Buy |
26,250
+1,000
| +4% | +$3.79K | 0.02% | 533 |
|
|
2018
Q1 | $80K | Sell |
25,250
-250
| -1% | -$1.01K | 0.01% | 559 |
|
|
2017
Q4 | $126K | Sell |
25,500
-2,400
| -9% | -$13.9K | 0.02% | 542 |
|
|
2017
Q3 | $192K | Buy |
27,900
+5,930
| +27% | +$37.4K | 0.03% | 506 |
|
|
2017
Q2 | $147K | Sell |
21,970
-15,370
| -41% | -$108K | 0.02% | 484 |
|
|
2017
Q1 | $299K | Sell |
37,340
-22,056
| -37% | -$186K | 0.05% | 382 |
|
|
2016
Q4 | $553K | Sell |
59,396
-7,790
| -12% | -$80.6K | 0.09% | 259 |
|
|
2016
Q3 | $712K | Buy |
67,186
+6,086
| +10% | +$60.6K | 0.12% | 204 |
|
|
2016
Q2 | $571K | Buy |
61,100
+1,350
| +2% | +$13.7K | 0.1% | 244 |
|
|
2016
Q1 | $622K | Sell |
59,750
-6,200
| -9% | -$56.6K | 0.11% | 220 |
|
|
2015
Q4 | $664K | Buy |
65,950
+12,700
| +24% | +$127K | 0.12% | 211 |
|
|
2015
Q3 | $445K | Buy |
53,250
+34,200
| +180% | +$453K | 0.08% | 273 |
|
|
2015
Q2 | $304K | Sell |
19,050
-3,500
| -16% | -$54.4K | 0.05% | 382 |
|
|
2015
Q1 | $318K | Sell |
22,550
-12,550
| -36% | -$163K | 0.05% | 366 |
|
|
2014
Q4 | $350K | Buy |
35,100
+2,300
| +7% | +$19.7K | 0.06% | 341 |
|
|
2014
Q3 | $282K | Buy |
32,800
+1,450
| +5% | +$12.7K | 0.05% | 391 |
|
|
2014
Q2 | $278K | Buy |
31,350
+12,200
| +64% | +$107K | 0.05% | 397 |
|
|
2014
Q1 | $178K | Buy |
+19,150
| New | +$168K | 0.05% | 344 |
|
Other funds holding OPK
OIM
Moors & Cabot's OPK Position: Q1 2021 in Review
Moors & Cabot sold out of Opko Health (OPK) in Q1 2021, closing a stake of 16,000 shares — an estimated $64K sold.
Moors & Cabot first reported a position in OPK in Q1 2014 and held it in 28 quarters. The position peaked at $712K in Q3 2016. 239 funds tracked by Wall St. Rank hold OPK as of Q1 2021.
- Moors & Cabot reported no remaining Opko Health position as of Q1 2021 after selling out during the quarter.
- Moors & Cabot sold 16,000 Opko Health shares in Q1 2021, an estimated $64K.
- Moors & Cabot first reported a position in Opko Health in Q1 2014 and held it in 28 quarters.
- Moors & Cabot's Opko Health position peaked at $712K in Q3 2016.
- 239 funds tracked by Wall St. Rank held Opko Health as of Q1 2021.
Based on Moors & Cabot's 13F filing for Q1 2021, filed 12 May 2021.